Cargando…

Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation

Recurrent or de novo non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) following liver transplantation (LT) is a frequent event being increasingly recognized over the last decade, but the influence of recurrent NASH on graft and patient outcomes is not yet established. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacob, Speranta, Beckebaum, Susanne, Iacob, Razvan, Gheorghe, Cristian, Cicinnati, Vito, Popescu, Irinel, Gheorghe, Liana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795078/ https://www.ncbi.nlm.nih.gov/pubmed/35096933 http://dx.doi.org/10.3389/fnut.2021.787430

Ejemplares similares

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
por: Iacob, Speranta, et al.
Publicado: (2022)

Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis
por: Iacob, Speranta, et al.
Publicado: (2022)

Pre and post-liver transplant outcome of cirrhotic patients with acute on chronic liver failure
por: Iacob, Speranta, et al.
Publicado: (2020)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Liquid biopsy for early detection of hepatocellular carcinoma
por: Manea, Ioana, et al.
Publicado: (2023)

Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?
por: Beckebaum, Susanne, et al.
Publicado: (2010)

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck
por: Iacob, Razvan, et al.
Publicado: (2022)

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion
por: Shen, Qingli, et al.
Publicado: (2010)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
por: Varzaru, Bianca, et al.
Publicado: (2023)

Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure
por: Dogan, Nurettin, et al.
Publicado: (2018)

Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening
por: Sorop, Andrei, et al.
Publicado: (2020)

Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
por: Duda, Dan G., et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Day, Kaitlin, et al.
Publicado: (2021)

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
por: Zambon Azevedo, Vittoria, et al.
Publicado: (2022)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Houttu, Veera, et al.
Publicado: (2021)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Zhu, Weifeng, et al.
Publicado: (2022)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Editorial: Nutrition in prevention and management of non-alcoholic fatty liver disease
por: Kouvari, Matina, et al.
Publicado: (2023)

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease
por: Zhang, Lijia, et al.
Publicado: (2022)

Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
por: Wu, Qiongbo, et al.
Publicado: (2022)

Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression
por: Balbuena, Emilio, et al.
Publicado: (2022)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
por: Hu, Yu-long, et al.
Publicado: (2023)

Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania
por: Goldiș, Adrian, et al.
Publicado: (2019)

Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis
por: Musazadeh, Vali, et al.
Publicado: (2022)

Neurologic complications in adult living donor liver transplant patients: an underestimated factor?
por: Saner, Fuat Hakan, et al.
Publicado: (2009)

Association Between Dietary Fiber Intake and Non-alcoholic Fatty Liver Disease in Adults
por: Zhao, Huimin, et al.
Publicado: (2020)

Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
por: Tokuhara, Daisuke
Publicado: (2021)

Cholangiocellular carcinoma occurrence after HCV eradication therapy: case series and review of the literature
por: Cerban, Razvan, et al.
Publicado: (2022)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Indications for Liver Transplantation
por: Beckebaum, S., et al.
Publicado: (2006)

Complex Dietary Topologies in Non-alcoholic Fatty Liver Disease: A Network Science Analysis
por: Xia, Yang, et al.
Publicado: (2020)

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Yin, Cong, et al.
Publicado: (2021)

Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
por: Sabirin, Faezah, et al.
Publicado: (2022)

Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
por: Hao, Shiqi, et al.
Publicado: (2022)

Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
por: Cao, Chujin, et al.
Publicado: (2023)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3u0kku60d6cc6upu4gbhbguao0